Partner Courtenay Brinckerhoff was quoted in a BioWorld article, “With BPCIA Dance Optional, Next Moves Up to Biosimilar Sponsors,” on July 24, 2015. The article discussed next steps for biosimilar sponsors after the Federal Circuit confirmed that the Biologic Price Competition and Innovation Act’s intricate patent information exchange is optional. Brinckerhoff said it’s likely that many biosimilar developers will choose not to follow the steps in place by BPCIA since it requires the biosimilar sponsor to give a copy of its application and other confidential manufacturing-related information to the reigning market champion.
People
Related News
04 October 2024
In the News
Rajiv Dharnidharka and Jeanette Barzelay Featured Across Legal Press for Move to Foley
Recent laterals Rajiv Dharnidharka and Jeanette Barzelay are featured across legal press for their arrival to Foley, including in the Law360 article, "Foley Adds 2 DLA Piper Business Litigators In San Francisco."
04 October 2024
In the News
Chanley Howell on AI IP Protection in Litigation – 'Judges are human'
Foley & Lardner LLP partner Chanley Howell shared insight on protecting the intellectual property behind emerging technologies like artificial intelligence in the Bloomberg Law article, "AI Put on Trial in ‘Life or Death’ Police Tech Clashes."
01 October 2024
In the News
Natasha Allen on DEI Challenges for Corporate Boards – 'Diversity is necessary for companies to succeed'
Foley & Lardner LLP partner Natasha Allen authored the article, "Navigating Today's DEI Challenges," in the November/December issue of Corporate Governance Advisor.